Imara
develops novel therapeutics for the treatment of sickle cell disease... Read moreImara
develops novel therapeutics for the treatment of sickle cell disease... Read more
2016
PublicMerged with Enliven Therapeutics, Inc.NASDAQIMRA
News
Mar 14, 2025
Owler
Imara Inc.: Imara's employee count changed from 46 in Dec 2023 to 62 in Dec 2024
May 11, 2023
StreetInsider
Press Release: Imara : Enliven Therapeutics Highlights Business Achievements and Reports First Quarter 2023 Financial Results
Feb 23, 2023
Citybizlist
Imara: Imara Announces Stockholder Approval of Merger With Enliven
Feb 10, 2023
Marketscreener
Imara: IMARA Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Jan 12, 2023
centralcharts
Press Release: Imara : IMARA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA
Dec 15, 2022
centralcharts
Press Release: Imara : SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFS, LBAI, OFIX, IMRA
Oct 18, 2022
Global Legal Chronicle
Imara: Enliven Therapeutics' Merger with Imara
Oct 17, 2022
The Business Journals
Imara: Struggling blood disorder biotech shuts down via reverse merger
Oct 15, 2022
Acrofan
Imara: IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA
Sep 08, 2022
Medthority
Imara: Imara Inc.to sell IMR 687 to Cadurion Pharma.
Imara Competitors
1
2
3
4
5
6
7
8
9
10